Routine antiemetic prophylaxis for non-fasted parturients having cesarean delivery with spinal anesthesia
Official title: Comparative Effectiveness of Routine Antiemetic Prophylaxis in Nonfasted Parturients Undergoing Cesarean Sections Under Spinal Anesthesia: A Prospective Randomized Controlled Trial
Run by Sanliurfa Education and Research Hospital · NCT07740577 · Data updated 2026-11-12
This trial tests whether giving a preventive antiemetic approach (ondansetron or a metoclopramide) reduces intraoperative nausea and vomiting in non-fasted women having emergency cesarean sections under spinal anesthesia.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Sanliurfa Education and Research Hospital Government |
| Locations | 1 site (Sanliurfa, Eyyübiye) |
| Status | Recruiting |
| Started | July 30, 2026 |
| Main results expected | January 1, 2027 |
| Study ends | January 2, 2027 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT07740577 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are non-fasted, ASA I-II pregnant women undergoing emergency cesarean delivery under spinal anesthesia who consent to participate.
✕Probably not a fit
Patients who do not experience nausea and vomiting or who have contraindications to the study drugs may derive no direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this randomized, double-blind study, non-fasted parturients undergoing emergency cesarean delivery under spinal anesthesia are assigned to receive either a 5-HT3 receptor antagonist or a dopamine receptor antagonist as routine antiemetic prophylaxis to prevent intraoperative nausea and vomiting. Eligible participants are ASA I-II pregnant women aged 18 or older with a singleton pregnancy. Participants and clinicians are blinded to treatment allocation, and outcomes focus on the incidence of intraoperative nausea and vomiting. The study aims to optimize antiemetic strategies to improve maternal comfort and perioperative safety during emergency cesarean deliveries.
Why it matters
Potential benefit: If successful, the approach could reduce intraoperative nausea and vomiting and improve maternal comfort and perioperative safety during cesarean delivery.
How similar studies have gone: Previous work has explored antiemetic prophylaxis in obstetric anesthesia, but direct comparisons between 5-HT3 antagonists and dopamine antagonists in this specific setting are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women scheduled for emergency cesarean delivery under spinal anesthesia * Non-fasted (full-stomach) parturients * American Society of Anesthesiologists (ASA) physical status I-II * Age ≥ 18 years * Singleton pregnancy * Ability to provide written informed consent Exclusion Criteria: * ASA physical status III or higher * Refusal to participate * Elective cesarean delivery (non-emergency cases) * Preoperative antiemetic use within 24 hours before surgery * Known allergy or contraindication to study drugs (ondansetron or metoclopramide) * Pre-existing gastrointestinal disorders (e.g., severe GERD, gastroparesis, bowel obstruction) * Psychiatric illness or current use of psychotropic medications * Preoperative anemia (as defined by institutional threshold, e.g., Hb \< 10 g/dL) * Intraoperative conversion to general anesthesia * Massive intraoperative hemorrhage (\>1000-1500 mL or requiring transfusion, depending on your protocol definition) * Intraoperative administration of additional sedative or antiemetic agents outside study protocol * Multiple gestation pregnancies
Where it's running
-
Sanliurfa Education and Research Hospital
Sanliurfa, Eyyübiye, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Tolga Karaçay
- Email: tkaracay35@gmail.com
- Phone: +905458718351
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neuraxial anesthesia and recovery quality after cesarean delivery
This study looks at whether the type of neuraxial anesthesia used for cesarean delivery affects how quickly and well new mothers recover.
-
Spinal anesthesia success in people with prior lower back surgery
This study will see if having previous lumbar spine surgery changes how well spinal anesthesia works on the first needle attempt in adults undergoing surgery.
-
Comparing ondansetron lozenge versus IV ondansetron to prevent shivering during cesarean section
This test will see if an ondansetron lozenge or IV ondansetron works better to prevent shivering in women having cesarean sections with spinal anesthesia.
-
Ondansetron lozenge versus IV to prevent shivering after tonsil removal in children
This test will see if an ondansetron lozenge works as well as intravenous ondansetron to prevent shivering in children aged 4 to 15 having a tonsillectomy.
-
Preventing low blood pressure after spinal anesthesia with a small dose of ketamine in orthopedic surgery
This trial will test if a single sub‑anesthetic IV dose of ketamine given before spinal anesthesia can prevent low blood pressure in adults having elective orthopedic surgery.
-
Understanding nausea and vomiting after elective C-sections under spinal anesthesia
This study looks at how often women feel nauseous or vomit after having a planned C-section with spinal anesthesia and what might cause it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.